Moxifloxacin vs. Polytrim for Conjunctivitis
| Status: | Completed |
|---|---|
| Conditions: | Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | 1 - 18 |
| Updated: | 4/21/2016 |
| Start Date: | March 2007 |
| End Date: | March 2012 |
A Single Blinded Clinical Trial Comparing Polytrim Ophthalmic Solution and Moxifloxacin Ophthalmic Solution for Treatment of Conjunctivitis.
The purpose of the study is to compare the effect of Polytrim Ophthalmic Solution and
Moxifloxacin Ophthalmic Solution in treating your child's pink eye. Both these medications
are approved by the Food and Drug Administration, for treatment of conjunctivitis. This
study will investigate if both of the medications are equally good.
Moxifloxacin Ophthalmic Solution in treating your child's pink eye. Both these medications
are approved by the Food and Drug Administration, for treatment of conjunctivitis. This
study will investigate if both of the medications are equally good.
Inclusion Criteria:
- 1 - 18 years of age with presumed bacterial conjunctivitis.
Exclusion Criteria:
- Previous antibiotics or to receive systemic antibiotic.
We found this trial at
1
site
University of Rochester The University of Rochester is one of the country's top-tier research universities....
Click here to add this to my saved trials
